EssilorLuxottica (OTCMKTS:ESLOY) Reaches New 52-Week Low – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s stock price hit a new 52-week low during trading on Tuesday . The stock traded as low as $116.28 and last traded at $116.7050, with a volume of 32733 shares. The stock had previously closed at $117.72.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Citigroup reiterated a “buy” rating on shares of EssilorLuxottica in a research report on Thursday, December 11th. Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. Kepler Capital Markets raised EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Finally, UBS Group upgraded shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. Two equities research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy”.

EssilorLuxottica Stock Performance

The company’s 50 day moving average price is $145.90 and its 200 day moving average price is $160.43. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.